A detailed history of Regal Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Regal Investment Advisors LLC holds 9,861 shares of ABT stock, worth $1.13 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
9,861
Previous 10,466 5.78%
Holding current value
$1.13 Million
Previous $1.09 Million 3.4%
% of portfolio
0.08%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $60,542 - $71,468
-605 Reduced 5.78%
9,861 $1.12 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $11,785 - $13,155
-117 Reduced 1.11%
10,466 $1.09 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $23,765 - $26,248
-217 Reduced 2.01%
10,583 $1.2 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $85,049 - $104,107
943 Added 9.57%
10,800 $1.19 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $11,845 - $14,212
-124 Reduced 1.24%
9,857 $954,000
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $27,613 - $30,767
-274 Reduced 2.67%
9,981 $1.09 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $23,924 - $28,160
247 Added 2.47%
10,255 $1.04 Million
Q4 2022

Mar 01, 2023

BUY
$95.06 - $111.52 $30,134 - $35,351
317 Added 3.27%
10,008 $1.1 Million
Q3 2022

Nov 15, 2022

BUY
$96.76 - $112.03 $62,506 - $72,371
646 Added 7.14%
9,691 $938,000
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $62,058 - $75,008
608 Added 7.21%
9,045 $983,000
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $148,910 - $181,586
1,306 Added 18.31%
8,437 $998,000
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $115 - $141
1 Added 0.01%
7,131 $1 Million
Q3 2021

Nov 05, 2021

BUY
$116.66 - $129.06 $133,575 - $147,773
1,145 Added 19.13%
7,130 $842,000
Q2 2021

Aug 09, 2021

BUY
$105.79 - $124.53 $633,153 - $745,312
5,985 New
5,985 $694,000
Q1 2021

May 12, 2021

SELL
$108.84 - $128.23 $680,903 - $802,206
-6,256 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $656,880 - $715,811
6,256 New
6,256 $685,000
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $316,738 - $463,158
-5,042 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
$78.51 - $87.4 $18,135 - $20,189
231 Added 4.8%
5,042 $438,000
Q3 2019

Nov 15, 2019

BUY
$81.84 - $88.74 $18,659 - $20,232
228 Added 4.97%
4,811 $403,000
Q2 2019

Jul 26, 2019

BUY
$72.88 - $85.0 $14,940 - $17,425
205 Added 4.68%
4,583 $385,000
Q1 2019

May 09, 2019

SELL
$66.22 - $80.06 $44,764 - $54,120
-676 Reduced 13.38%
4,378 $350,000
Q4 2018

Feb 04, 2019

SELL
$65.56 - $74.27 $47,334 - $53,622
-722 Reduced 12.5%
5,054 $366,000
Q3 2018

Nov 05, 2018

BUY
$60.81 - $73.36 $114,261 - $137,843
1,879 Added 48.22%
5,776 $424,000
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $164,995 - $182,105
-2,866 Reduced 42.38%
3,897 $238,000
Q1 2018

Apr 25, 2018

BUY
$56.27 - $63.62 $70,675 - $79,906
1,256 Added 22.81%
6,763 $405,000
Q4 2017

Feb 06, 2018

SELL
$53.68 - $57.47 $17,875 - $19,137
-333 Reduced 5.7%
5,507 $314,000
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $280,670 - $313,257
5,840
5,840 $312,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.